Back

Synonymous mutations in AAV Rep enhance genome packaging in a library selection

Azim, T.; Myerscough, D.; Silberg, J.

2024-10-08 molecular biology
10.1101/2024.10.08.617207 bioRxiv
Show abstract

When producing Adeno-Associated Virus (AAV) gene therapies, a significant fraction of capsids can lack the desired DNA cargo. In AAV, Rep proteins mediate DNA packaging and virus assembly, suggesting that changes in Rep activity, expression, or DNA binding might affect genome packaging. To understand how mutations in the Rep gene affect activity, we selected a library of Rep mutants for their ability to produce active virions. By sequencing the Rep gene following the purification of viruses that package AAV genomes, we identified Rep mutants having non-synonymous mutations with a range of cellular activities. Surprisingly, synonymous mutations within the p19 promoter were enriched to the greatest extent, increasing in abundance by 102 to 104-fold. When the most highly enriched mutant was used to package a synthetic DNA cargo into the AAV capsid, the packaging efficiency could not be differentiated from native Rep. These findings suggest that these synonymous mutations enhance AAV genome packaging into capsids by affecting Rep-DNA interactions. They also suggest that silent sequence changes in the DNA cargo packaged by Rep can be used to tune packaging DNA packaging efficiency. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=121 SRC="FIGDIR/small/617207v2_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@1ba20d0org.highwire.dtl.DTLVardef@c05a6corg.highwire.dtl.DTLVardef@70a248org.highwire.dtl.DTLVardef@ae587c_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of Virology
456 papers in training set
Top 0.5%
14.3%
2
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.1%
10.4%
3
iScience
1063 papers in training set
Top 0.8%
7.2%
4
PLOS Pathogens
721 papers in training set
Top 2%
6.4%
5
Nucleic Acids Research
1128 papers in training set
Top 3%
6.4%
6
Molecular Therapy Methods & Clinical Development
13 papers in training set
Top 0.1%
4.2%
7
Nature Communications
4913 papers in training set
Top 37%
4.0%
50% of probability mass above
8
eLife
5422 papers in training set
Top 26%
3.6%
9
Viruses
318 papers in training set
Top 2%
3.2%
10
Cell Reports
1338 papers in training set
Top 17%
3.1%
11
Cell Reports Methods
141 papers in training set
Top 1%
2.4%
12
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.3%
2.1%
13
Cell Systems
167 papers in training set
Top 7%
1.7%
14
ACS Synthetic Biology
256 papers in training set
Top 2%
1.7%
15
Science Advances
1098 papers in training set
Top 20%
1.5%
16
Scientific Reports
3102 papers in training set
Top 66%
1.2%
17
PLOS Biology
408 papers in training set
Top 14%
1.2%
18
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 2%
1.1%
19
Virus Evolution
140 papers in training set
Top 1%
1.1%
20
PLOS ONE
4510 papers in training set
Top 64%
0.9%
21
Molecular Therapy
71 papers in training set
Top 2%
0.9%
22
PLOS Computational Biology
1633 papers in training set
Top 23%
0.8%
23
Mobile DNA
27 papers in training set
Top 0.2%
0.7%
24
mBio
750 papers in training set
Top 11%
0.7%
25
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 47%
0.6%
26
Frontiers in Microbiology
375 papers in training set
Top 10%
0.6%
27
Genome Biology
555 papers in training set
Top 8%
0.6%
28
JCI Insight
241 papers in training set
Top 8%
0.6%